1,163
Views
15
CrossRef citations to date
0
Altmetric
Original Articles

Treating Insomnia: A Review of Patient Perceptions Toward Treatment

, , &

REFERENCES

  • Aarons, G. A. (2004).Mental health provider attitudes toward adoption of evidence-based practice: The Evidence-Based Practice Attitude Scale (EBPAS). Mental Health Services Research, 6(2), 61–74.
  • Aikens, J. E., & Rouse, M. E. (2005). Help-seeking for insomnia among adult patients in primary care. Journal of the American Board of Family Practice, 18(4), 257–261.
  • Allain, H., Bentue-Ferrer, D., Breton, S. L., Polard, E., & Gandon, J. M. (2003). Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg. Human Psychopharmacology, 18(5), 369–374.
  • American Academy of Sleep Medicine. (2005). Insomnia. In M. J. Sateia (Ed.), The international classification of sleep disorders (2nd ed., pp. 1–31). Westchester, NY: American Academy of Sleep Medicine.
  • American Psychiatric Association. (2000). Sleep disorders. In M. B. First (Ed.), Diagnostic and statistical manual of mental disorders (4th ed., text rev., pp. 597–662). Washington, DC: American Psychiatric Association.
  • American Psychiatric Association. (2013). Sleep-wake disorders. In Diagnostic and statistical manual of mental disorders (5th ed.), Arlington, VA: Author.
  • Archer, M., Brown, J. S. L., Idusohan, H., Coventry, S., Manoharan, A., & Espie, C. A. (2009). The development and evaluation of a large-scale self-referral CBT-I intervention for men who have insomnia: An exploratory study. Journal of Behavioral and Cognitive Psychotherapy, 37(3), 239–248.
  • Azad, N., Byszewski, A., Sarazin, F. F., McLean, W., & Koziarz, P. (2003). Hospitalized patients’ preference in the treatment of insomnia: Pharmacological versus non-pharmacological. Canadian Journal of Clinical Pharmacology, 10(2), 89–92.
  • Barbosa, C. D., Balp, M.-M., Kulich, K., Germain, N., & Rofail, D. (2012). A literature review to explore the link between treatment satisfaction and adherence, compliance, and persistence. Patient Preference and Adherence, 6, 39–48.
  • Barter, G., & Cormack, M. (1996). The long-term use of benzodiazepines: Patients’ views, accounts and experiences. Journal of Family Practice, 13(6), 491–497.
  • Beaumont, G., & Holland, R. L. (1990). A multi-centre open study in general practice to evaluate the efficacy and acceptability of zopiclone 7.5 mg nocte in patients requiring the prescription of an hypnotic. International Clinical Psychopharmacology, 5(Suppl. 2), 11–20.
  • Bluestein, D., Healey, A. C., & Rutledge, C. M. (2011). Acceptability of behavioral treatments for insomnia. Journal of the American Board of Family Medicine, 24(3), 272–280.
  • Boon, H., Kachan, N., & Boecker, A. (2012). Use of natural health products: How does being “natural” affect choice? Medical Decision Making. doi:10.1177/0272989x12451056
  • Bourin, M., & Malinge, M. (1996). A new design of trial for hypnotics comparison: A doubleblind cross-over trial with patient’s preference assessment and continuation of the preferred treatment. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 20(3), 373–385.
  • Bowling, A., & Ebrahim, S. (2001). Measuring patients’ preferences for treatment and perceptions of risk. Quality in Health Care, 10(Suppl 1), i2–i8. doi:10.1136/qhc.0100002.
  • Bowling, A., & Rowe, G. (2005). “You decide, doctor.” What do patient preference arms in clinical trials really mean? Journal of Epidemiology and Community Health, 59(11), 914–915.
  • Brown, J. S. L., Cochrane, R., & Cardone, D. (1999). Large-scale health promotion stress workshops: Promotion, programme content and client response. Journal of Mental Health, 8(4), 391–402. doi:10.1080/09638239917319
  • Busto, U. E., Sproule, B. A., Knight, K., & Herrmann, N. (2001). Use of prescription and nonprescription hypnotics in a Canadian elderly population. Canadian Journal of Clinical Pharmacology, 8(4), 213–221.
  • Buysse, D. J., Reynolds, C. F., III, Monk, T. H., Berman, S. R., & Kupfer, D. J. (1989). The Pittsburgh sleep quality index: A new instrument for psychiatric practice and research. Psychiatry Research, 28(2), 193–213. doi:10.1016/0165-1781(89)90047-4
  • Carey, T. J., Moul, D. E., Pilkonis, P., Germain, A., & Buysse, D. J. (2005). Focusing on the experience of insomnia. Behavioral Sleep Medicine, 3(2), 73–86.
  • Carney, C. E., Buysse, D. J., Ancoli-Israel, S., Edinger, J. D., Krystal, A. D., Lichstein, K. L., & Morin, C. M. (2012). The consensus sleep diary: Standardizing prospective sleep self-monitoring. Sleep, 35(2), 287–302.
  • Chaudoir, P., Jarvie, N., & Wilcox, G. (1983). The acceptability of a non-benzodiazepine hypnotic (Zopiclone) in general practice. Journal of International Medical Research, 11(6), 333.
  • Cheung, J. M., Bartlett, D.J., Armour, C. L., Glozier, N., & Saini, B. (2013). Insomnia patients’ help-seeking experiences. Behavioral Sleep Medicine, 12(2), 106–122. doi:10.1080/15402002.2013.764529
  • Davidson, J. R., Aime, A., Ivers, H., & Morin, C. M. (2009). Characteristics of individuals with insomnia who seek treatment in a clinical setting versus those who volunteer for a randomized controlled trial. Behav Sleep Med, 7(1), 37–52.
  • Dockhorn, R. J., & Dockhorn, D. W. (1996). Zolpidem in the treatment of short-term insomnia: A randomized, double-blind, placebo-controlled clinical trial. Clinical Neuropharmacology, 19(4), 333–340.
  • Dollman, W. B., LeBlanc, V. T., & Roughead, E. E. (2003). Managing insomnia in the elderly—What prevents us using non-drug options? Journal of Clinical Pharmacy and Therapeutics, 28(6), 485–491. doi:10.1046/j.0269-4727.2003.00523.x
  • Drake, C., Richardson, G., Roehrs, T., Scofield, H., & Roth, T. (2004). Vulnerability to stress-related sleep disturbance and hyperarousal. Sleep, 27(2), 285–292.
  • Dyas, J. V., Apekey, T. A., Tilling, M., Orner, R., Middleton, H., & Siriwardena, A. N. (2010). Patients’ and clinicians’ experiences of consultations in primary care for sleep problems and insomnia: A focus group study. British Journal of General Practice, 60(574), e180–e200.
  • Epstein, D. R., Babcock-Parziale, J. L., Haynes, P. L., & Herb, C. A. (2012). Insomnia treatment acceptability and preferences of male Iraq and Afghanistan combat Veterans and their healthcare providers. Journal of Rehabilitation Research and Development, 49(6), 867–878.
  • Espie, C. A. (2009). “Stepped care”: A health technology solution for delivering cognitive behavioral therapy as a first line insomnia treatment. Sleep, 32(12), 1549–1558.
  • Espie, C. A., Barrie, L. M., & Forgan, G. S. (2012). Comparative investigation of the psychophysiologic and idiopathic insomnia disorder phenotypes: Psychologic characteristics, patients’ perspectives, and implications for clinical management. Sleep, 35(3), 285–393.
  • Espie, C. A., Brooks, D., & Lindsay, W. R. (1989). An evaluation of tailored psychological treatment of insomnia. Journal of Behavior Therapy and Experimental Psychiatry, 20(2), 143–153.
  • Fabre, L. F., Jr., McLendon, D. M., & Harris, R. T. (1976). Preference studies of triazolam with standard hypnotics in out-patients with insomnia. Journal of International Medical Research, 4(4), 247–254.
  • Francisco, V. T., & Butterfoss, F. D. (2007). Social validation of goals, procedures, and effects in public health. Health Promotion Practice, 8(2), 128–133. doi:10.1177/1524839906298495
  • Fung, A., & Lai, V. (2009). Local coping strategies adopted by people with insomnia: A pilot study. Sleep and Hypnosis, 11(1), 5–8.
  • Garb, L. R., Dawson, S., Cousins, J. C., Sidani, S., Epstein, D., Moritz, P., & Bootzin, R. (2013). Number of prior treatments tried predicts pre-treatment insomnia severity but is not a moderator of response to behavioral treatment [Abstract Supplement]. Sleep, 36, A207.
  • Green, A., Hicks, J., & Wilson, S. (2008). The experience of poor sleep and its consequences: A qualitative study involving people referred for cognitive-behavioural management of chronic insomnia. British Journal of Occupational Therapy, 71(5), 196–204.
  • Gum, A. M., Areán, P. A., Hunkeler, E., Tang, L., Katon, W., Hitchcock, P.,::: Unützer, J. (2006). Depression treatment preferences in older primary care patients. Gerontologist, 46(1), 14–22.
  • Hagger, M. S., & Orbell, S. (2003). A meta-analytic review of the common-sense model of illness representations. Psychology and Health, 18(2), 141–184. doi:10.1080/088704403100081321
  • Harvey, L., Inglis, S. J., & Espie, C. A. (2002). Insomniacs’ reported use of CBT components and relationship to long-term clinical outcome. Behavioral Research Therapy, 40(1), 75–83.
  • Healey, A. C., Rutledge, C. M., & Bluestein, D. (2011). Validation of the Insomnia Treatment Acceptability Scale (ITAS) in primary care. Journal of Clinical Psychology in Medical Settings, 18(3), 235–242.
  • Hedner, J., Yaeche, R., Emilien, G., Farr, I., & Salinas, E. (2000). Zaleplon shortens subjective sleep latency and improves subjective sleep quality in elderly patients with insomnia. The Zaleplon Clinical Investigator Study Group. International Journal of Geriatric Psychiatry, 15(8), 704–712. doi:10.1002/1099-1166(200008)15:8<704::AID-GPS183>3.3.CO;2-J
  • Henry, D., McClellen, D., Rosenthal, L., Dedrick, D., & Gosdin, M. (2008). Is sleep really for sissies? Understanding the role of work in insomnia in the US. Social Science and Medicine, 66(3), 715–726.
  • Henry, D., Rosenthal, L., Dedrick, D., & Taylor, D. (2013). Understanding patient responses to insomnia. Behavioral Sleep Medicine, 11(1), 40–55.
  • Hogan, A., Clark, G., & Scott, N. (2003). Patient perspectives on the experience of sleeplessness. Australasian Journal of Clinical Pharmacy, 1(2), 4–8.
  • Homsey, M., & O’Connell, K. (2012). Use and success of pharmacologic and nonpharmacologic strategies for sleep problems. Journal of the American Academy of Nurse Practitioners, 24(10), 612–623.
  • Horne, R. (1999). Patients’ beliefs about treatment: The hidden determinant of treatment outcome? Journal of Psychosomatic Research, 47(6), 491–495. doi:http://dx.doi.org/10.1016/S0022-3999(99)00058-6
  • Iliffe, S., Curran, H. V., Collins, R., Yuen Kee, S. C., Fletcher, S., & Woods, B. (2004). Attitudes to long-term use of benzodiazepine hypnotics by older people in general practice: Findings from interviews with service users and providers. Aging and Mental Health, 8(3), 242–248. doi:10.1080/13607860410001669778
  • Johnson, J. E. (1997). Insomnia, alcohol, and over-the-counter drug use in old-old urban women. Journal of Community Health Nursing, 14(3), 181–188.
  • Joseph, D. N., & Hossain, M. (1985). Lormetazepam (Loramet) in the elderly: An acceptability study. Journal of International Medical Research, 13(4), 209–213.
  • Kleinman, L., Buysse, D. J., Harding, G., Lichstein, K., Kalsekar, A., & Roth, T. (2013). Patient-reported outcomes in insomnia: Development of a conceptual framework and endpoint model. Behavioral Sleep Medicine, 11(1), 23–36.
  • Kyle, S. D., Crawford, M. R., Morgan, K., Spiegelhalder, K., Clark, A. A., & Espie, C. A. (2013). The Glasgow Sleep Impact Index (GSII): A novel patient-centered measure for assessing sleep-related quality of life impairment in Insomnia Disorder. Sleep Medicine, 14(6), 493–501. doi:http://dx.doi.org/10.1016/j.sleep.2012.10.023
  • Kyle, S. D., Espie, C. A., & Morgan, K. (2010). “Not just a minor thing, it is something major, which stops you from functioning daily”: Quality of life and daytime functioning in insomnia. Behavioral Sleep Medicine, 8(3), 123–140.
  • Kyle, S. D., Morgan, K., Spiegelhalder, K., & Espie, C. A. (2011). No pain, no gain: An exploratory within-subjects mixed-methods evaluation of the patient experience of sleep restriction therapy (SRT) for insomnia. Sleep Medicine, 12(8), 735–747.
  • Larsen, D. L., Attkisson, C. C., Hargreaves, W. A., & Nguyen, T. D. (1979). Assessment of client/patient satisfaction: Development of a general scale. Evaluation and Program Planning, 2(3), 197–207. doi:http://dx.doi.org/10.1016/0149-7189(79)90094-6
  • Lewith, G. T., Godfrey, A. D., & Prescott, P. (2005). A single-blinded, randomized pilot study evaluating the aroma of Lavandula augustifolia as a treatment for mild insomnia. Journal of Alternative and Complementary Medicine, 11(4), 631–637. doi:10.1089/acm.2005.11.631
  • Lipani, J. A. (1978). Preference study of the hypnotic efficacy of triazolam 0.125 mg compared to placebo in geriatric patients with insomnia. Current Therapeutic Research-Clinical and Experimental, 24(4), 397–402.
  • Mah, L., & Upshur, R. E. G. (2002). Long-term benzodiazepine use for insomnia in patients over the age of 60: Discordance of patient and physician perceptions. BMC Family Practice, 3, 1–6.
  • Mead, N., & Bower, P. (2000). Patient-centeredness: A conceptual framework and review of the empirical literature. Social Science and Medicine, 51(7), 1087–1110. doi:http://dx.doi.org/10.1016/S0277-9536(00)00098-8
  • Mead, N., & Bower, P. (2002). Patient-centered consultations and outcomes in primary care: A review of the literature. Patient Education and Counseling, 48(1), 51–61. doi:http://dx.doi.org/10.1016/S0738-3991(02)00099-X
  • Miltenberger, R. G. (1990). Assessment of treatment acceptability: A review of the literature. Topics in Early Childhood Special Education, 10(3), 24–38. doi:10.1177/027112149001000304
  • Miranda, J. (2009). An exploration of participants’ treatment preferences in a partial RCT. Canadian Journal of Nursing Research, 36(3), 101–114.
  • Montano, D. E., & Kasprzyk, D. (2008). Theory of reasoned action, theory of planned behavior, and the integrated behavioral model. Health Behavior and Health Education: Theory, Research, and Practice, 4, 67–95.
  • Morgan, K., Gregory, P., Tomeny, M., David, B. M., & Gascoigne, C. (2012). Self-help treatment for insomnia symptoms associated with chronic conditions in older adults: A randomized controlled trial. Journal of the American Geriatrics Society, 60(10), 1803–1810.
  • Morin, C. M., Gaulier, B., Barry, T., & Kowatch, R. A. (1992). Patients’ acceptance of psychological and pharmacological therapies for insomnia. Sleep, 15(4), 302–305.
  • Mulley, A. G., Trimble, C., & Glyn, E. (2012). Stop the silent misdiagnosis: Patients’ preferences matter. BMJ, 345. doi:10.1136/bmj.e6572
  • Nolan, L., & O’Malley, K. (1988). Patients, prescribing, and benzodiazepines. European Journal of Clinical Pharmacology, 35(3), 225–229.
  • Ohayon, M. (2002). Epidemiology of insomnia: What we know and what we still need to learn. Sleep Medicine Reviews, 6(2), 97–111. doi:10.1053/smrv.2002.0186
  • Omvik, S., Pallesen, S., Bjorvatn, B., Sivertsen, B., Havik, O. E., & Nordhus, I. H. (2010). Patient characteristics and predictors of sleep medication use. International Clinical Psychopharmacology, 25(2), 91–100.
  • Palmer, P. D. (2013). Exploring attitudes to financial reporting in the Australian not-for-profit sector. Accounting & Finance, 53(1), 217–241. doi:10.1111/j.1467-629X.2011.00456.x
  • Revicki, D. A. (2004). Patient assessment of treatment satisfaction: methods and practical issues. Gut, 53(Suppl 4), iv40–iv44. doi:10.1136/gut.2003.034322
  • Roehrs, T., Bonahoom, A., Pedrosi, B., Rosenthal, L., & Roth, T. (2001). Treatment regimen and hypnotic self-administration. Psychopharmacology, 155(1), 11–17.
  • Roehrs, T., Pedrosi, B., Rosenthal, L., & Roth, T. (1996). Hypnotic self administration and dose escalation. Psychopharmacology, 127(2), 150–154.
  • Roehrs, T., Pedrosi, B., Rosenthal, L., Zorick, F., & Roth, T. (1997). Hypnotic self administration: Forced-choice versus single-choice. Psychopharmacology, 133(2), 121–126.
  • Seligman, M. E. (1995). The effectiveness of psychotherapy: The Consumer Reports study. American Psychologist, 50(12), 965.
  • Sidani, S., Epstein, D. R., Bootzin, R. R., Moritz, P., & Miranda, J. (2009). Assessment of preferences for treatment: Validation of a measure. Research in Nursing and Health, 32(4), 419–431.
  • Sidani, S., Miranda, J., Epstein, D. R., Bootzin, R. R., Cousins, J., & Moritz, P. (2009). Relationships between personal beliefs and treatment acceptability, and preferences for behavioral treatments. Behaviour Research and Therapy, 47(10), 823–829.
  • Siriwardena, A. N., Qureshi, M. Z., Dyas, J. V., Middleton, H., & Orner, R. (2008). Magic bullets for insomnia? Patients’ use and experiences of newer (Z drugs) versus older (benzodiazepine) hypnotics for sleep problems in primary care. British Journal of General Practice, 58(551), 417–422.
  • Sproule, B. A., Busto, U. E., Buckle, C., Herrmann, N., & Bowles, S. (1999). The use of non-prescription sleep products in the elderly. International Journal of Geriatric Psychiatry, 14(10), 851–857.
  • Stepanski, E., Koshorek, G., Zorick, F., Glinn, M., Roehrs, T., & Roth, T. (1989). Characteristics of individuals who do or do not seek treatment for chronic insomnia. Psychosomatics, 30(4), 421–427.
  • Stinson, K., Tang, N. K. Y., & Harvey, A. G. (2006). Barriers to treatment seeking in primary insomnia in the United Kingdom: A cross-sectional perspective. Sleep, 29(12), 1643–1646.
  • Tang, N. K., & Harvey, A. G. (2006). Altering misperception of sleep in insomnia: Behavioral experiment versus verbal feedback. Journal of Consulting and Clinical Psychology, 74(4), 767–776.
  • Thorndike, F. P., Saylor, D. K., Bailey, E. T., Gonder-Frederick, L., Morin, C. M., & Ritterband, L. M. (2008). Development and perceived utility and impact of an internet intervention for insomnia. E-Journal of Applied Psychology, 4(2), 32–42.
  • Toth, C. M., & Redline, S. (2013). Putting the patient into patient-centered care. Behavioral Sleep Medicine, 11(5), 390–393. doi:10.1080/15402002.2013.838128
  • Totman, R. (1976). Cognitive dissonance in the placebo treatment of insomnia: A pilot experiment. British Journal of Medical Psychology, 49(4), 393–400.
  • Vincent, N., & Lewycky, S. (2009). Logging on for better sleep: RCT of the effectiveness of online treatment for insomnia. Sleep, 32(6), 807–815.
  • Vincent, N., Lewycky, S., & Finnegan, H. (2008). Barriers to engagement in sleep restriction and stimulus control in chronic insomnia. Journal of Consulting and Clinical Psychology, 76(5), 820–828.
  • Vincent, N., & Lionberg, C. (2001). Treatment preference and patient satisfaction in chronic insomnia. Sleep, 24(4), 411–417.
  • Vincent, N., Penner, S., & Lewycky, S. (2006). What predicts patients’ perceptions of improvement in insomnia? Journal of Sleep Research, 15(3), 301–308.
  • Wickwire, E. M., Schumacher, J. A., & Clarke, E. J. (2009). Patient-reported benefits from the pre-sleep routine approach to treating insomnia: Findings from a treatment development trial. Sleep and Biological Rhythms, 7(2), 71–77.
  • Yamashiro, T., Homma, M., & Kohda, Y. (2008). Assessment of hypnotic effects and patient satisfaction in empirical use of sleep medicines. Journal of Clinical Pharmacy and Therapeutics, 33(3), 273–278.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.